2-Deoxyribose-5-phosphate
aldolase (DERA) catalyzes the reversible
conversion of acetaldehyde and glyceraldehyde-3-phosphate into deoxyribose-5-phosphate.
DERA is used as a biocatalyst for the synthesis of drugs such as statins
and is a promising pharmaceutical target due to its involvement in
nucleotide catabolism. Despite previous biochemical studies suggesting
the catalytic importance of the C-terminal tyrosine residue found
in several bacterial DERAs, the structural and functional basis of
its participation in catalysis remains elusive because the electron
density for the last eight to nine residues (i.e., the C-terminal
tail) is absent in all available crystal structures. Using a combination
of NMR spectroscopy and molecular dynamics simulations, we conclusively
show that the rarely studied C-terminal tail of E.
coli DERA (ecDERA) is intrinsically
disordered and exists in equilibrium between open and catalytically
relevant closed states, where the C-terminal tyrosine (Y259) enters
the active site. Nuclear Overhauser effect distance restraints, obtained
due to the presence of a substantial closed state population, were
used to derive the solution-state structure of the ecDERA closed state. Real-time NMR hydrogen/deuterium exchange experiments
reveal that Y259 is required for efficiency of the proton abstraction
step of the catalytic reaction. Phosphate titration experiments show
that, in addition to the phosphate-binding residues located near the
active site, as observed in the available crystal structures, ecDERA contains previously unknown auxiliary phosphate-binding
residues on the C-terminal tail which could facilitate in orienting
Y259 in an optimal position for catalysis. Thus, we present significant
insights into the structural and mechanistic importance of the ecDERA C-terminal tail and illustrate the role of conformational
sampling in enzyme catalysis.